Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$28.82 - $77.35 $37,206 - $99,858
-1,291 Closed
0 $0
Q1 2022

Apr 20, 2022

SELL
$48.25 - $100.49 $2,316 - $4,823
-48 Reduced 3.58%
1,291 $85.5 Million
Q4 2021

Jan 14, 2022

BUY
$88.71 - $120.43 $8,427 - $11,440
95 Added 7.64%
1,339 $134 Million
Q3 2021

Oct 12, 2021

BUY
$98.77 - $132.17 $122,869 - $164,419
1,244 New
1,244 $155,000
Q2 2021

Jul 26, 2021

SELL
$109.77 - $165.68 $218,771 - $330,200
-1,993 Closed
0 $0
Q1 2021

May 06, 2021

SELL
$127.04 - $179.1 $548,431 - $773,174
-4,317 Reduced 68.42%
1,993 $304,000
Q4 2020

Mar 30, 2021

BUY
$99.96 - $135.93 $242,502 - $329,766
2,426 Added 62.46%
6,310 $813,000
Q4 2020

Feb 05, 2021

BUY
$99.96 - $135.93 $388,244 - $527,952
3,884 New
3,884 $813,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $4.8B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Koshinski Asset Management, Inc. Portfolio

Follow Koshinski Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Koshinski Asset Management, Inc. with notifications on news.